Michel Chonchol

Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.

Neutrophil dysfunction and infection risk in end-stage renal disease.

Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice.

Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience.

Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.

Temporary worsening of renal function after aortic surgery is associated with higher long-term mortality.

Relationship of uric acid with progression of kidney disease.

Diagnosis and management of ischemic nephropathy.

Long-term outcomes after coronary artery bypass grafting: preoperative kidney function is prognostic.

Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction.

Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.

Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.

Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography.

The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.

Chronic kidney disease is associated with angiographic coronary artery disease.

Renal insufficiency and mortality in patients with known or suspected coronary artery disease.

Beta-blockers for coronary heart disease in chronic kidney disease.

Beta-blockade in chronic dialysis patients.

Hemoglobin levels and coronary artery disease.

Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis.

Kidney function and progression of carotid intima-media thickness in a community study.

Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.

Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly.

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.

Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome.

Assessing the benefits and harms of statin treatment in patients with chronic kidney disease.

Reversible acute kidney injury following contrast exposure and the risk of long-term mortality.

Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis.

Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.

Rapid kidney function decline and mortality risk in older adults.

25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey.

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.

Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).

The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.

25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease.

Serum phosphorus and cardiovascular mortality in type 2 diabetes.

Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients.

Coronary and aortic calcifications in patients new to dialysis.

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.

Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study.

Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis.

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension.

Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study.

Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.

Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.

Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease.

Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease.

The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease.

Higher systolic blood pressure is associated with progression of carotid intima-media thickness in patients with chronic kidney disease.

Cystatin C and sudden cardiac death risk in the elderly.

Disorders of hemostasis associated with chronic kidney disease.

Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease.

Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.

Increased fructose associates with elevated blood pressure.

Elevated preoperative phosphorus levels are an independent risk factor for cardiovascular mortality.

Relationship between kidney function and risk of asymptomatic peripheral arterial disease in elderly subjects.

Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey).

Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis.

Influence of left ventricular dysfunction (diastolic versus systolic) on long-term prognosis in patients with versus without diabetes mellitus having elective peripheral arterial surgery.

The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-VII (DECREASE-VII) trial.

Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study.

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.

The influence of polyvascular disease on the obesity paradox in vascular surgery patients.

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome.

25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults.

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?

Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.

Extra-skeletal effects of vitamin D deficiency in chronic kidney disease.

Hemostatic disorders in type 1 diabetes mellitus.

Preoperative left ventricular dysfunction predisposes to postoperative acute kidney injury and long-term mortality.

Phosphate and cardiovascular disease.

Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures.

Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.

Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study.

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

Relationship between blood pressure and incident chronic kidney disease in hypertensive patients.

The role of phosphorus in the development and progression of vascular calcification.

High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.

C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.

Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study.

Vascular Endothelial Function Is Not Related to Serum Uric Acid in Healthy Adults.

Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.

Racial differences in markers of mineral metabolism in advanced chronic kidney disease.

Insulin resistance, cystatin C, and mortality among older adults.

Frequent hemodialysis: a way to improve physical function?

Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality.

The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease.

Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis.

Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.

Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis.

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars.

Influence of aortic valve calcium on outcome in patients undergoing peripheral vascular surgery.

Cardiovascular disease: Should statin therapy be expanded in patients with CKD?

Association between serum 25-hydroxyvitamin D and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-94.

25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease.

Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes.

Update in nephrology: evidence published in 2011.

Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study).

Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Uric acid as a target of therapy in CKD.

Hemoglobin A1c and arterial and ventricular stiffness in older adults.

Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients.

Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994.

Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure.

Dietary zinc intake and kidney stone formation: evaluation of NHANES III.

Relationships Between Serum and Urine Phosphorus With All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study.

Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

Chronic kidney disease: Cystatin-C-based eGFR: what is it telling us?

The association of prevalent kidney stone disease with mortality in US adults: the National Health and Nutrition Examination Survey III, 1988-1994.

Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study.

Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study.

Vitamin D and kidney stone disease.

Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study.

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study.

Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.

Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness.

Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.

Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.

Vascular calcification in end-stage renal disease.

Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.

Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo.

Cardiovascular disease in CKD in 2013: Reducing cardiovascular risk--light at the end of the tunnel.

Bioactive lipid mediators in polycystic kidney disease.

Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes.

Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.

Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes.

Nonalcoholic Fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.

Estimated GFR and Circulating 24,25-Dihydroxyvitamin D3 Concentration: A Participant-Level Analysis of 5 Cohort Studies and Clinical Trials.

Dietary Sodium and Potassium Intake Is Not Associated With Elevated Blood Pressure in US Adults With No Prior History of Hypertension.